14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CLSK vs XRPN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Armada Acquisition Corp. II (XRPN) captures the overall head-to-head institutional edge over Cleanspark Inc (CLSK) on higher Unified Composite conviction (56.0/100 HOLD vs. 50.7/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CLSK wins 3–2 across the 6-pillar growth and valuation breakdown. CLSK trades at $6.33 (30.5x Forward P/E, -189.5% operating margin) versus XRPN at $7.43 (N/M Forward P/E, 0.0% operating margin).
Growth vs. Quality Trade-Off: XRPN earns the overall head-to-head edge with a stronger Unified Composite Score (56.0/100 HOLD vs. CLSK 50.7/100 HOLD) and 0.48β · 132% Vol risk profile, whereas CLSK leads top-line expansion (-30.5% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile XRPN is in a Breakdown options structure phase (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLSK vs XRPN. Trailing 12-month operating profitability (CLSK -189.5% vs XRPN 0.0%) and valuation multiples (CLSK 30.5x vs XRPN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $596.8M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CLSK vs XRPN Key Questions & Quantitative Answers
As of Nov 16, 2026, Armada Acquisition Corp. II (XRPN) captures the overall head-to-head institutional edge over Cleanspark Inc (CLSK) on higher Unified Composite conviction (56.0/100 HOLD vs. 50.7/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CLSK wins 3–2 across the 6-pillar growth and valuation breakdown. CLSK trades at $6.33 (30.5x Forward P/E, -189.5% operating margin) versus XRPN at $7.43 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: XRPN earns the overall head-to-head edge with a stronger Unified Composite Score (56.0/100 HOLD vs. CLSK 50.7/100 HOLD) and 0.48β · 132% Vol risk profile, whereas CLSK leads top-line expansion (-30.5% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile XRPN is in a Breakdown options structure phase (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CLSK leads the Growth & Scale pillar: CLSK posts -30.5% YoY revenue growth and +491.6% YoY earnings growth on $679M TTM revenue (47.0% gross margin, -189.5% operating margin), compared with XRPN at +0.0% YoY revenue growth and +4.6% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, CLSK generates $679M in USD-normalized revenue versus N/A for XRPN. In operating R&D and SG&A reinvestment, CLSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XRPN.
CLSK screens cheaper on headline valuation multiples. CLSK trades at 30.5x Forward P/E, 30.5x Trailing P/E, N/M PEG, and 4.8x EV/Revenue (unreported FCF margin), whereas XRPN trades at N/M Forward P/E, 149.5x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLSK (-68.6% ROE) versus XRPN (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, CLSK carries 100.6% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.66x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.26β · 126% Vol realized risk). By comparison, XRPN carries 110.0% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.48β · 132% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.